Medical device recalls Moderate risk

Associates of Cape Cod, Inc. recalls Fungitell Kit, Catalog FT001 - Product Usage: The Fungitell assay is a potease zymogen-based colorimetric assay for the…

Recall date
December 19, 2018
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1329-2019
FDA classification
Class II
Brand / firm
Associates of Cape Cod, Inc.
Sold / distributed
Worldwide distribution - US nationwide in the states of CA, FL, MD, UT, VA and countries of Singapore, South Africa, United Kingdo.m

Why it was recalled

The kits may contain the incorrect number of components or the kits may be missing components.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Fungitell Kit, Catalog FT001 - Product Usage: The Fungitell assay is a potease zymogen-based colorimetric assay for the qualitative detection of (1-3)Beta-D Glucan in the serum of patients with symptoms of,or medical conditions predisposing the patient to, invasive fungal infection. The serum concentration of (1-3)Beta-D Glucan, a major cell wall component of various medically important fungi, can be used as an aid in teh diagnosis of deep-seated mycoses and funemias. A positve result does not indicate which genus of fungi may be causing the infection. (1-3)Beta-D Glucan titers should be used in conjunction with other diagnostic procedures, such as microbiological culture, histological examination of biopsy samples and radiological examination.

Get recall alerts

Free email alert whenever Associates of Cape Cod, Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Associates of Cape Cod, Inc.